Profit before tax (PBT) fell 51.87% YoY to Rs 34.01 crore in Q2 FY25. EBITDA stood at Rs 82.4 crore, registering the de-growth of 25.7% as compared with Rs 110.9 crore posted in corresponding quarter last year. EBITDA margin remained flat at 28% during the quarter. Meanwhile, the company's wholly owned subsidiary named Anupam General Trading FZE has been registered in Jebel Ali Free Zone (JAFZA), Dubai, UAE. Anupam General Trading FZE is registered with initial capital of AED 20,000. The objective of Anupam General Trading FZE is the trading and storage of chemicals including handling of distribution and sales of chemicals for export markets. Anand Desai, managing director, Anupam Rasayan, said, 'In Q2FY25, we were nearing the end of a demand slump in the Agro segment, and we are now seeing a good recovery. The Pharma and Polymer segments, meanwhile, have been showing robust growth, fuelled by the launch of over 17 new molecules in FY24 and 3 additional molecules in H1FY25. As these products gain traction, we expect their contribution to grow. Additionally, the planned launch of more than 3 new molecules in the coming months should further accelerate growth in these areas. Our consolidated operating revenue for the quarter was Rs 294 crore, representing a QoQ growth of 14%, with a stable EBITDA margin of 28% in Q2FY25. We anticipate revenue to normalize as volumes increase in the latter half of the year. With the new capacity, scaling of recently launched fluorinated molecules, and signed LOIs and contracts, we are optimistic about strong growth over the medium term. Anupam Rasayan India is one of the leading companies engaged in the custom synthesis (CSM) and manufacturing of specialty chemicals in India. Its business verticals are life science related specialty chemicals comprising products related to agrochemicals, personal care and pharmaceuticals, and other specialty chemicals, comprising specialty pigment and dyes, and polymer additives.Powered by Capital Market - Live

Profit before tax (PBT) fell 51.87% YoY to Rs 34.01 crore in Q2 FY25. EBITDA stood at Rs 82.4 crore, registering the de-growth of 25.7% as compared with Rs 110.9 crore posted in corresponding quarter last year. EBITDA margin remained flat at 28% during the quarter. Meanwhile, the company's wholly owned subsidiary named Anupam General Trading FZE has been registered in Jebel Ali Free Zone (JAFZA), Dubai, UAE. Anupam General Trading FZE is registered with initial capital of AED 20,000. The objective of Anupam General Trading FZE is the trading and storage of chemicals including handling of distribution and sales of chemicals for export markets. Anand Desai, managing director, Anupam Rasayan, said, 'In Q2FY25, we were nearing the end of a demand slump in the Agro segment, and we are now seeing a good recovery. The Pharma and Polymer segments, meanwhile, have been showing robust growth, fuelled by the launch of over 17 new molecules in FY24 and 3 additional molecules in H1FY25. As these products gain traction, we expect their contribution to grow. Additionally, the planned launch of more than 3 new molecules in the coming months should further accelerate growth in these areas. Our consolidated operating revenue for the quarter was Rs 294 crore, representing a QoQ growth of 14%, with a stable EBITDA margin of 28% in Q2FY25. We anticipate revenue to normalize as volumes increase in the latter half of the year. With the new capacity, scaling of recently launched fluorinated molecules, and signed LOIs and contracts, we are optimistic about strong growth over the medium term. Anupam Rasayan India is one of the leading companies engaged in the custom synthesis (CSM) and manufacturing of specialty chemicals in India. Its business verticals are life science related specialty chemicals comprising products related to agrochemicals, personal care and pharmaceuticals, and other specialty chemicals, comprising specialty pigment and dyes, and polymer additives. The scrip advanced 1.69% to settle at Rs 734.55 on Thursday, 14 November 2024.Powered by Capital Market - Live

Anupam Rasayan India will hold a meeting of the Board of Directors of the Company on 14 November 2024Powered by Capital Market - Live

Anupam Rasayan India approved the issue and allotment of 37,804 fully paid-up equity shares of face value of INR 10/- each under Anupam ' Employees Stock Option Plan 2020 of the Company pursuant to exercise of Options by the eligible employees. Powered by Capital Market - Live

Anupam Rasayan India announced that the Annual General Meeting (AGM) of the company will be held on 30 September 2024.Powered by Capital Market - Live

JSW Energy Ltd, Usha Martin Ltd, Alembic Pharmaceuticals Ltd, KSB Ltd are among the other stocks to see a surge in volumes on BSE today, 09 September 2024.Anupam Rasayan India Ltd clocked volume of 5926 shares by 10:46 IST on BSE, a 2.82 times surge over two-week average daily volume of 2099 shares. The stock lost 0.01% to Rs.762.35. Volumes stood at 4504 shares in the last session.JSW Energy Ltd recorded volume of 2.96 lakh shares by 10:46 IST on BSE, a 2.82 times surge over two-week average daily volume of 1.05 lakh shares. The stock gained 3.19% to Rs.732.20. Volumes stood at 52490 shares in the last session.Usha Martin Ltd witnessed volume of 96010 shares by 10:46 IST on BSE, a 2.53 times surge over two-week average daily volume of 37895 shares. The stock increased 3.00% to Rs.361.85. Volumes stood at 51303 shares in the last session.Alembic Pharmaceuticals Ltd clocked volume of 44024 shares by 10:46 IST on BSE, a 2.5 times surge over two-week average daily volume of 17591 shares. The stock gained 4.72% to Rs.1,159.90. Volumes stood at 32541 shares in the last session.KSB Ltd saw volume of 10906 shares by 10:46 IST on BSE, a 2.25 fold spurt over two-week average daily volume of 4856 shares. The stock dropped 3.42% to Rs.865.35. Volumes stood at 2143 shares in the last session.Powered by Capital Market - Live

Anupam Rasayan India has fixed 18 September 2024 as record date for final dividend, if declared. Powered by Capital Market - Live

Net profit of Anupam Rasayan India declined 89.84% to Rs 3.92 crore in the quarter ended June 2024 as against Rs 38.60 crore during the previous quarter ended June 2023. Sales declined 34.21% to Rs 254.20 crore in the quarter ended June 2024 as against Rs 386.39 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales254.20386.39 -34 OPM %20.9226.25 - PBDT36.8695.98 -62 PBT16.2277.30 -79 NP3.9238.60 -90 Powered by Capital Market - Live

Anupam Rasayan India will hold a meeting of the Board of Directors of the Company on 13 August 2024.Powered by Capital Market - Live